國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 967789      線上人數 : 821
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    類別統計

    近3年內發表的文件:59(17.82%)
    含全文筆數:328(99.09%)

    文件下載次數統計
    下載大於0次:328(100.00%)
    下載大於100次:313(95.43%)
    檔案下載總次數:138832(77.75%)

    最後更新時間: 2024-12-04 00:57


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目101-125 / 331. (共14頁)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2020-01 Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial Pancreas. 2020 Jan;49(1):62-75.
    2019-12 Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
    2019-11-27 Characterization of a fiber bundle-based real-time ultrasound/photoacoustic imaging system and its in vivo functional imaging applications Micromachines. 2019 Nov 27;10(12):Article number 820.
    2019-10 The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703.
    2019-10 A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FO Annals of Oncology. 2019 Oct;30(Suppl. 5):321.
    2019-09 Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors Oncogene. 2019 Aug;38:6550-6565.
    2019-09 Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8 Theranostics. 2019 Sep. 23;9(24):7168-7183.
    2019-07-28 Nomogram for predicting survival in patients treated with liposomal irinotecan plus fluorouracil and leucovorin in metastatic pancreatic cancer Cancers. 2019 Jul 28;11(8):Article number 1068.
    2019-07 Preventive hypothermia as a neuroprotective strategy for paclitaxel-induced peripheral neuropathy Pain. 2019 Jul;160(7):1505-1521.
    2019-07 Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer Journal of Hematology and Oncology. 2019 Jul;12:Article number 79.
    2019-06-24 Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903.
    2019-06-21 Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map International Journal of Oncology. 2019 Jun 21;55(2):536-546.
    2019-06 Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol BMC Cancer. 2019 Jun;19:Article number 640.
    2019-05-27 Deciphering the potential role of hox genes in pancreatic cancer Cancers. 2019 May 27;11(5):Article number 734.
    2019-05-20 Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer Molecular Cancer. 2019 May 20;18:Article number 96.
    2019-05 Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial Journal of Geriatric Oncology. 2019 May;10(3):427-435.
    2019-04-17 Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma Cancers. 2019 Apr 17;11(4):Article number 547.
    2019-04-10 Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
    2019-04-08 Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes BMC Cancer. 2019 Apr 8;19:Article number 337.
    2019-03 A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens Gastric Cancer. 2019 Mar;22(2):344-354.
    2019-03 Foreword Hepatobiliary Surgery and Nutrition. 2019 Mar;8(Suppl. 1):S1.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling Oncogene. 2019 Feb;38(8):1340-1353.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] Oncogene. 2019 Feb;38(8):1354.
    2019-02 Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4) Annals of Oncology. 2019 Feb;30(2):250-258.
    2019-02 NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors European Journal of Cancer. 2019 Feb;108:78-87.

    顯示項目101-125 / 331. (共14頁)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋